OTC Watch

All stocks / VSBC

VITASPRING BIOMEDICAL CO. LTD. VSBC

Vitaspring Biomedical (VSBC): a late 10-Q notice in September 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Late filingEstimated float OTCIDCalifornia, USA
Live quote on OTC Markets

Market listing

Full name
VITASPRING BIOMEDICAL CO LTD
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 05
Source: Stockwatch, 2026-11-17

The financial report, and what it means

Annual figures to 2026-01-31
The report says
Revenue
$0
Net loss
($415,368)
What it means

It spends more than it earns

Under strain

The company lost $415,368 in the year. It reported no sales.

The report says
Cash and cash equivalents
$2,084
Net cash used in operating activities
($2,688)
What it means

The cash could run out soon

Under strain

It had $2,084 in the bank and used about $224 a month. At that pace the money lasts about 9 months unless it borrows or sells more shares.

The report says
Total assets
$14,676
Total liabilities
$4,445,244
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $14,676. Its debts and unpaid bills add up to $4.4 million. That is about $302.89 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Late filing2026-09-15

Filed NT 10-Q on 2026-09-15: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Estimated float2026-09-14

Estimated float about 207,030,030 shares as of 2026-09-14: 207,030,030 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2026-04-17
207.0M
2026-04-23
207.0M
2026-04-30
207.0M
2026-06-01
207.0M
2026-06-15
207.0M
2026-06-17
207.0M
2026-07-31
207.0M
2026-09-14
207.0M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-09-17 10-QFORM 10-Q
2026-09-15 NT 10-QFORM NT 10-Q
2026-09-10 8-KFORM 8-K
2026-06-17 10-QFORM 10-Q
2026-06-17 10-QFORM 10-Q
2026-06-17 10-QFORM 10-Q
2026-06-17 10-KFORM 10-K
2026-06-15 10-QFORM 10-Q
2026-06-08 10-KFORM 10-K
2026-05-06 10-QFORM 10-Q
2026-04-22 10-QFORM 10-Q
2026-04-02 10-QFORM 10-Q

Common questions about VSBC

Does VSBC file reports with the SEC?

Yes. Vitaspring Biomedical files with the SEC under company number 0001697884. The most recent filing we hold is a 10-Q dated 2026-09-17.

Source record

How many VSBC shares are outstanding?

207,030,030 shares as of 2026-09-14, as reported to the SEC.

Source record

Has VSBC filed reports late?

Yes. In the last 12 months it filed 1 late-filing notice, most recently a NT 10-Q on 2026-09-15. A notice means a report was not ready on time; check whether the report followed.

Source record

Is Vitaspring Biomedical making money?

The company lost $415,368 in the year. It reported no sales. (Annual figures to 2026-01-31. Facts from the company's own report, not a recommendation.)

Source record